In a statement to ET, BI confirmed it has obtained separate orders granting ad-interim injunction that restrains the two domestic pharmaceu...

Under its brand Vicra, Dr. Reddy's is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim....

With Jardiance, BI has the advantage of significantly reducing cardiovascular risks associated with most patients with diabetes.